Paid Clinical Trials Paid Clinical Trials > Browse Categories > Medications / Interventions > Aa > Autoantibodies

Autoantibodies

Autoantibodies

All Categories Medications / Interventions » Aa » Autoantibodies



  • Condition:   Lung Cancer
    Intervention:  
    Sponsors:   Baptist Cancer Institute;   Douglas W. Johnson MD, FACR
    Recruiting - verified April 2012

  • Condition:   Thyroiditis, Autoimmune
    Interventions:   Dietary Supplement: Anatabloc Supplement;   Dietary Supplement: Placebo
    Sponsors:   Rock Creek Pharmaceuticals, Inc.;   Rock Creek Pharmaceuticals, Inc.
    Recruiting - verified April 2012

  • Condition:   Living-Donor Kidney Transplants
    Intervention:  
    Sponsors:   Northwestern University;   Northwestern University
    Recruiting - verified March 2012

  • Condition:   Type 1 Diabetes
    Intervention:   Drug: ferumoxytol
    Sponsors:   Massachusetts General Hospital;   Jason Gaglia;   National Institute of Allergy and Infectious Diseases (NIAID);   Harvard University
    Recruiting - verified January 2012

  • Conditions:   Congenital Heart Block;   Neonatal Lupus;   Autoantibody-Associated Heart Block
    Intervention:   Drug: Hydroxychloroquine
    Sponsors:   New York University School of Medicine;   New York University School of Medicine
    Recruiting - verified June 2011

  • Condition:   Diabetes Mellitus
    Interventions:   Drug: Metformin;   Drug: Placebo
    Sponsors:   University of Massachusetts, Worcester;   University of Massachusetts, Worcester
    Recruiting - verified April 2012

  • Condition:   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Interventions:   Drug: Standard of care treatment;   Drug: eculizumab
    Sponsors:   University of North Carolina, Chapel Hill;   University of North Carolina, Chapel Hill;   Alexion Pharmaceuticals;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting - verified December 2011

  • Condition:   Hemophilia A
    Intervention:   Biological: OBI-1
    Sponsors:   Inspiration Biopharmaceuticals, Inc.;   Inspiration Biopharmaceuticals, Inc.
    Recruiting - verified April 2012

  • Conditions:   Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
    Intervention:   Drug: Teplizumab
    Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Center for Research Resources (NCRR);   Juvenile Diabetes Research Foundation;   American Diabetes Association
    Recruiting - verified February 2012

  • Conditions:   Type 1 Diabetes;   Type 2 Diabetes;   Immunologically Mediated Type 1 Diabetes;   Anti Beta-Cell Autoantibodies;   Autoimmunity
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting - verified September 2011

  • Condition:   Kidney Cancer
    Interventions:   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method
    Sponsors:   City of Hope Medical Center;   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting - verified November 2011

  • Condition:   Eye Diseases
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Eye Institute (NEI)
    Recruiting - verified September 2011

  • Conditions:   Dermatomyositis;   Polymyositis;   Idiopathic Inflammatory Myopathy;   Healthy
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Environmental Health Sciences (NIEHS)
    Recruiting - verified September 2011